Glenmark Pharma US unit launches Lacosamide oral solution used to treat seizures

Glenmark Pharma Share Price | The company said the solution is bioequivalent and therapeutically equivalent to the reference listed drug, Vimpat Oral Solution, 10 mg/ml of UCB, Inc.

Leave a Reply

Your email address will not be published. Required fields are marked *